Project Details
Description
A Randomised, Double-Blind, Phase III Efficacy and Safety Study of Cediranib (RECENTIN) when Added to Cisplatin plus a Fluoropyrimidine, Compared with Cisplatin plus a Fluoropyrimidine alone, in Patients with Previously Untreated, Locally Advanced or Met
| Status | Finished |
|---|---|
| Effective start/end date | 3/31/10 → 12/31/12 |
Funding
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.